Patents by Inventor Frank Grenier

Frank Grenier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Driveway alarm system
    Patent number: 6166660
    Abstract: A driveway alarm system for disposing along a driveway of a home or business for warning an occupant of the premise about an object, including a vehicle, on the driveway, or for warning a driver of a vehicle about an overhanging object in the driveway. The overhead warning and driveway alarm system includes a solar panel, a battery, a magnetic field generator, a driveway probe and a transmitter. The solar panel charges the battery which powers the driveway probe and the transmitter. The driveway probe creates a magnetic field. When the magnetic field is disturbed, the transmitter is activated, sending a radio signal to the receiver. In operation, when a car or other object disturbs the magnetic field proximate the driveway probe sensor, the transmitter provides a radio alert signal to the indoor subsystem.
    Type: Grant
    Filed: September 15, 1999
    Date of Patent: December 26, 2000
    Inventor: Frank Grenier
  • Stabilized standards and calibrators containing rapamycin and tactrolimus bound to FK binding proteins
    Patent number: 5736401
    Abstract: The present invention is directed to an in vitro aqueous composition comprising a drug, preferably tacrolimus or rapamycin, having enhanced stability. The invention utilizes a binding protein, preferably FKBP, to stabilize the drug in an aqueous matrix.
    Type: Grant
    Filed: September 27, 1996
    Date of Patent: April 7, 1998
    Assignee: Abbott Laboratories
    Inventors: Frank Grenier, Thomas F. Holzman, Allan H. Smith, Alan C. Tsurutani
  • Stabilized standards and calibrators containing rapamycin and tacrolimus bound to anti-rapamycin and anti-tacrolimus antibodies
    Patent number: 5635406
    Abstract: The present invention is directed to an in vitro aqueous composition comprising a drug, preferably tacrolimus or rapamycin, having enhanced stability. The invention utilizes a binding protein, preferably antibodies to tacrolimus or rapamycin, to stabilize the drug in an aqueous matrix.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: June 3, 1997
    Assignee: Abbott Laboratories
    Inventors: Frank Grenier, Thomas F. Holzman, Allan H. Smith, Alan C. Tsurutani